The problem of drug resistance will have "China Standards"

The spread of multiple drug -resistant bacteria in the world seriously threatens the diagnosis and treatment of clinical infectious diseases. The problem of drug resistance may make humans face a "useless" situation.

In order to cope with increasingly complex drug resistance, on August 6, the National Health and Health Commission's clinical anti -microbiological drug sensitivity discount point research and standard formulation expert committee, which is the establishment of the National Pharmaceutical Special Committee.

Due to the enhancement of disease resistance of pathogenic microorganisms, more and more common infections will become more difficult to treat, and new drug resistance mechanisms continue to appear and complicated.

China has previously borrowed European and American standards, but in clinical practice, it was found that due to factors such as the use of drugs and dosage differences, the direct borrowing of European and American standards produced deviations.

Xu Yingchun, chairman of the National Pharmaceutical Special Committee and director of the inspection department of the Beijing Union Hospital, said that chemical drugs are not sensitive to bacterial sensitivity and resistant to resistance. It determines whether we use this drug, but there is a standard for resistance and sensitivity. So where does this standard come from? Our country is blank, and does not target the pathogens of our Chinese population or the pathogens infected by our Chinese people. So it is imperative to build our own Chinese standards.

After the establishment of the National Pharmaceutical Special Committee, experts in domestic clinical microbiology, clinical pharmacology, and clinical infectious diseases will be organized in China to establish a sensitivity system for anti -microbiological drugs in my country, clinical evaluation and reasonable use of drugs, and drug resistance monitoring Carry out various research work in other fields.

Antibiotic use is incorporated into public hospital performance assessment

Antibiotics are the most important categories of antimicromic drugs, including penicillin, cephalosporin, amino glycoside, macromone, tetracycline, chlorophyterocyromycin, polypeptide, stagnomycin, etc. Essence

It is worth mentioning that the "Notice" mentioned that local health administrative departments at all levels should include rational use of anti -microbiological drugs in hospital review, public hospital performance assessment, and reasonable medication assessment, and increase the weight of the assessment appropriately. Give play to the role of command sticks.

In order to curb the abuse of antibacterial drugs, the country launched a three -year national action in 2011 to focus on improving the rational use of antibiotics of public hospitals in level 2 and above; in 2012 In August of the year, the "Administrative Measures for the Clinical Application of Antibacterial Drugs" was officially implemented.

On March 29, 2019, the "Notice of the General Office of the National Health and Health Commission on continuing to do a good job in the management of the clinical application of antibacterial drugs" requires that local and medical institutions shall regularly organize the evaluation of the clinical effects of antibacterial drug clinical application management.

All medical institutions shall submit monitoring data to the "two networks" (national antibacterial drug clinical application monitoring network and bacterial resistance monitoring network) in accordance with the requirements, and ensure the quality of data.

On July 20, 2020, the "Notice of the General Office of the National Health and Health Commission on the Management of Clinical Application of Antibacterial Drugs" required that medical institutions that have established information systems must embed the relevant requirements of antibacterial drug management into the information system, and through informatization The means to realize the intelligent management of key links such as prescription authority grants, prescription opening, prescription review, prevention of drug use, and specimen inspection.

A medical institutions above the second level are encouraged to join the provincial or national or national antibacterial drug clinical application monitoring network, bacterial resistance monitoring network and fungal disease monitoring network, and submit relevant data in accordance with regulations.

In April 2021, the official website of the State Health and Health Commission Medical and Health Management Bureau issued the "Notice on Further Strengthening the Management of Anti -micro Biotherapy and Containing Drug Resistance" (hereinafter referred to as the "Notice"), requiring to further strengthen the management of anti -microbiological drugs, and actively respond to microbial biology Drug resistance, continuously improve the level of clinical and reasonable medication, and protect people's health.

The "Notice" is based on the problem of microbial drug resistance, which is currently highly concerned by the current society, and puts forward specific requirements from five aspects, including requiring to pay great attention from various places and continuously implement work deployment and responsibility. Essence

The "Notice" requires to further increase the number of "two networks" access to the Internet, and play the role of "two networks" monitoring and supervision.

Before the end of September 2021, comprehensive hospitals above the second level should join the "two networks"; encourage other second -level medical institutions to enter the network; actively explore the methods and methods of grass -roots medical institutions to enter the network.

New access to the Internet should strengthen leadership and support and actively create conditions for monitoring work. Make full use of information technology to collect, statistical and analyze related data, strengthen monitoring and supervision, continue to evaluate the management effect, and take targeted intervention measures to improve the level of medication.

Pilot research on anti -microbial drugs in vitro -sensitive discount points, gradually establish a standard system for anti -microbiological drugs in my country, and guide clinical science and accurate medication.

It is worth mentioning that the "Notice" mentioned that local health administrative departments at all levels should include rational use of anti -microbiological drugs in hospital review, public hospital performance assessment, and reasonable medication assessment, and increase the weight of the assessment appropriately. Give play to the role of command sticks.

This article comprehensive CCTV News Dahe Health News

- END -